未找到相关数据
Results of ACCURACY: A phase 2 trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) harboring Notch activating mutations (Notchmut).
被引：0
作者：
Ferrarotto, Renata
Metcalf, Robert
Rodriguez, Cristina P.
Muzaffar, Jameel
Even, Caroline
Perez, Augusto
Herpen, Carla M. L. -Van
Oliva, Marc
Xia, Bing
Bowles, Daniel W.
Popovtzer, Aharon
Winquist, Eric
Wirth, Lori J.
Hao, Desiree
Kang, Hyunseok
Hotte, Sebastien J.
Stemmer, Salomon M.
Mehra, Ranee
Worden, Francis P.
Ho, Alan Loh
机构：
[1] Univ Texas MD Anderson Canc Ctr, Thorac Head & Neck Med Oncol, Houston, TX USA
[2] Christie NHS Fdn Trust, Dept Head & Neck, Manchester, England
[3] Univ Washington, Seattle, WA USA
[4] H Lee Moffitt Canc Ctr Res Inst, Head & Neck & Endocrine Oncol, Tampa, FL USA
[5] Gustave Roussy, Head & Neck Dept, Villejuif, France
[6] Sarah Cannon Res Inst, Orlando, FL USA
[7] Radboud Univ Nijmegen, Dept Med Oncol, Med Ctr, Nijmegen, Netherlands
[8] Catalan Inst Oncol ICO Lhospitalet, Phase Drug Dev Program, Barcelona, Spain
[9] USC Keck, Div Oncol, Norris Comprehens Canc Ctr, Sch Med, Los Angeles, CA USA
[10] Univ Colorado, Div Med Oncol, Ctr Canc, Aurora, CO USA
[11] Hadassah Med Ctr, Sharett Inst Oncol, Jerusalem, Israel
[12] Univ Western Ontario, Dept Oncol, London, ON, Canada
[13] Harvard Med Sch, Massachusetts Gen Hosp, Hematol Oncol, Boston, MA USA
[14] Univ Calgary, Dept Med Oncol, Tom Baker Canc Ctr, Calgary, AB, Canada
[15] UCSF Helen Diller Family Comprehens Canc Ctr, Hematol Oncol, San Francisco, CA USA
[16] Juravinski Canc Ctr, Hamilton, ON, Canada
[17] Rabin Med Ctr, Inst Oncol, Petah Tiqwa, Israel
[18] Univ Maryland, Greenebaum Comprehens Canc Ctr, Baltimore, MD USA
[19] Univ Michigan, Rogel Canc Ctr, Endocrine Oncol Clin, Ann Arbor, MI USA
[20] Mem Sloan Kettering Canc Ctr, Div Solid Tumor Oncol, Head & Neck Serv, New York, NY USA
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6046
引用
收藏
页数：1
相关论文